Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J

Verdict comes as lawyers prepare for the first federal talcum powder trials to go before a jury, involving claims that will be repeated in tens of thousands of ovarian cancer lawsuits being pursued by women in the federal court system.

A Pennsylvania jury has ordered Johnson & Johnson to pay a family $250,000 in a talcum powder lawsuit that went to trial in state court, holding the manufacturer liable for the death of a woman who died of ovarian cancer after using Baby Powder products around her genitals for nearly 50 years.

The ovarian cancer lawsuit was originally filed by Gayle Emerson in 2019, who died about six months after filing the claim, raising claims that will repeated in a series of federal bellwether trials expected to go to trial over the next few years.

Johnson & Johnson currently faces nearly 90,000 Baby Powder lawsuits and Shower-to-Shower lawsuits filed in federal and state courts nationwide, each raising similar allegations that exposure to the talcum powder products led to ovarian or other forms of cancer.

Plaintiffs say the company marketed talc-based products for feminine hygiene purposes, despite knowing that the raw ingredients may be contaminated with asbestos. They also claim that routine exposure to the contaminated talc caused them to develop ovarian cancer and other reproductive system cancers, and early trial cases are being closely watched to gauge how juries may respond to certain evidence and testimony likely to be repeated throughout the litigation.

Following three days of deliberations, the jury handed down the verdict in the Emerson case on February 13, awarding her family $50,000 in compensatory damages, and another $200,000 in punitive damages, designed to punish the company for recklessly endangering consumers.

The verdict comes about two months after a Baltimore jury awarded another woman $1.5 billion in December 2025, for a peritoneal mesothelioma diagnosis following talcum powder exposure. That same month, a Minnesota jury ordered the company to pay $65.5 million to Anna Jean Houghton Carley, who also said she developed mesothelioma because of talcum powder use. In addition, a separate California jury awarded $40 million to two women who filed talcum powder cancer lawsuits after being diagnosed with ovarian cancer.

Johnson & Johnson has promised to appeal the verdict and claims that the low amount of the award was a victory.

Federal Talcum Powder Lawsuits

All federal ovarian cancer talcum powder lawsuits are consolidated as part of a multidistrict litigation, or MDL, in the District of New Jersey before U.S. District Judge Michael A. Shipp, who is overseeing coordinated discovery and pretrial proceedings for about 70,000 federal claims.

The first bellwether trial from the federal litigation is expected to begin later this year and will involve a talcum powder ovarian cancer lawsuit brought by Carter Judkins, who indicates she was diagnosed with ovarian cancer in December 2016, after more than 30 years of using Johnson’s Baby Powder as part of her daily routine.

While the outcome of this and other bellwether trials will have no binding effect on the rest of the claims, they will be used to gauge how juries may respond to evidence and testimony that will be repeated throughout the litigation. What those juries decide could help determine the potential size of any talcum powder cancer settlement payouts Johnson & Johnson ultimately agrees to pay to resolve future lawsuits.

Sign up for more legal news that could affect you or your family.